3 unloved ASX shares set to take off: analysts

The Australian share market has just hit all-time highs. But these fund managers say there are still bargains out there.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Despite worries about rising inflation, the ASX has been on fire in recent weeks.

On Thursday, the S&P/ASX 200 Index (ASX: XJO) closed above 7,300 for the first time in history. On Friday, it pushed ahead a further 0.13%.

But does this mean the share market is on the verge of an indelicate correction? The bears, like Jeremy Grantham, obviously think so.

Even though the general market is at record highs, however, there are still rising companies on the Australian bourse that aren't as well-known to investors.

Perhaps they're not in glamorous industries, or they're just playing the tortoise to quietly win the long race.

Fortunately, there are professional fund managers whose job is to find businesses that are being underrated by everyone else.

"There's a lot of cheap companies out there," Wilson Asset Management portfolio manager Oscar Oberg told a company video.

"You just got to find them… We're very bullish [on] small caps and micro caps going forward."

Oberg and his colleague Tobias Yao revealed 3 shares held by Wilson funds that he feels the market doesn't fully appreciate yet:

2 fingers with happy faces next to finger drawn with a sad face.

Image source: Getty Images

Ardent Leisure Group Ltd (ASX: ALG)

In the US, Ardent owns the chain of Main Event ten-pin bowling and arcade centres in 43 locations. The company in Australia is best known for running theme parks, such as Dreamworld on the Gold Coast.

"The US recovery is actually going really well on the back of strong government support for consumers and the much more relaxed COVID restrictions," said Yao.

He added that at the current valuation, the risk-reward trade-off is "really appealing" for his team.

"Our view is that at the current share price, you're not paying anything for the theme parks division, which is over $100 million on the balance sheet."

Ardent shares closed Friday at precisely $1, meaning a 40.85% gain for the year to date.

Virtus Health Ltd (ASX: VRT)

Virtus is one of the large IVF providers in Australia, with a market capitalisation of around $516 million.

Yao's team bought the stock 12 months ago on the COVID recovery prospects, but the reasons for holding it now have evolved.

"Our current investment thesis is premised on the new CEO's ability to find new revenue streams — precision fertility, genetics testing, and also digitisation services that they can use for companies overseas."

Virtus stocks finished Friday at $6.42, which is 17.15% up from the start of the year.

The price is still attractive, according to Yao, who works on the WAM Capital Limited (ASX: WAM), WAM Research Limited (ASX: WAX), WAM Microcap Ltd (ASX: WMI) and WAM Active Limited (ASX: WAA) funds.

"It's trading on 14 times price-to-earnings ratio, so we think a lot of these additional optionalities are not being priced into the current share price."

Seven West Media Ltd (ASX: SWM)

Oberg picked out one of the 3 free-to-air television networks in Australia as his example of a hot bargain.

"Seven West Media, which we own in WAM Capital and Microcap, that's trading on a price-to-earnings multiple ratio of 3.5 times earnings right now. It's less than half of what Channel Nine [Nine Entertainment Co Holdings Ltd (ASX: NEC)] trades on," he said. 

"A company like that is sitting right now in our wheelhouse — it's a company we like to invest in."

Seven West shares finished last week at 42 cents, which is 15.3% up just this year.

Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Virtus Health Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A man in his office leans back in his chair with his hands behind his head looking out his window at the city.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Wooden house models on a table with a man using a calculator.
Broker Notes

Why this expert believes it's time to exit positions in REA Group shares

One broker is calling time on this ASX 200 stock.

Read more »

Happy young couple riding a motorbike together.
Broker Notes

7 ASX 200 shares with reaffirmed buy ratings this week

Brokers retained a positive view on Santos, Zip, AMP, and other shares this week. 

Read more »

Sad man sitting at desk and grabbing his head as he looks at a laptop.
Broker Notes

Downgrade alert! 5 ASX 200 shares downgraded by experts this week

Brokers reduced their ratings on Wisetech, Harvey Norman, Ansell, and other stocks this week. 

Read more »

Woman holding several shopping bags.
Broker Notes

ASX retail shares are down 13% in 2026. Here's what Morgan Stanley is worried about

The sector has fallen hard, and concerns remain.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

Forget Xero shares! Broker tips this top ASX tech stock for 24% gains

This ASX tech stock has rocketed 143% in a year, and a leading broker forecasts another 24% of gains to…

Read more »

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

This ASX nickel miner could jump 57%, Macquarie says

A resumption of dividends could also be on the cards.

Read more »

Business people discussing project on digital tablet.
Broker Notes

Buy, hold, sell: James Hardie, REA Group, and Ramelius shares

Analysts have given their verdict on these shares.

Read more »